11-73975005-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003355.3(UCP2):c.*2C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,578,444 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
UCP2
NM_003355.3 3_prime_UTR
NM_003355.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.71
Publications
2 publications found
Genes affected
UCP2 (HGNC:12518): (uncoupling protein 2) Mitochondrial uncoupling proteins (UCP) are members of the larger family of mitochondrial anion carrier proteins (MACP). UCPs separate oxidative phosphorylation from ATP synthesis with energy dissipated as heat, also referred to as the mitochondrial proton leak. UCPs facilitate the transfer of anions from the inner to the outer mitochondrial membrane and the return transfer of protons from the outer to the inner mitochondrial membrane. They also reduce the mitochondrial membrane potential in mammalian cells. Tissue specificity occurs for the different UCPs and the exact methods of how UCPs transfer H+/OH- are not known. UCPs contain the three homologous protein domains of MACPs. This gene is expressed in many tissues, with the greatest expression in skeletal muscle. It is thought to play a role in nonshivering thermogenesis, obesity and diabetes. Chromosomal order is 5'-UCP3-UCP2-3'. [provided by RefSeq, Jul 2008]
UCP2 Gene-Disease associations (from GenCC):
- hyperinsulinism due to UCP2 deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BS2
High AC in GnomAd4 at 170 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UCP2 | NM_003355.3 | c.*2C>G | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000663595.2 | NP_003346.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UCP2 | ENST00000663595.2 | c.*2C>G | 3_prime_UTR_variant | Exon 8 of 8 | NM_003355.3 | ENSP00000499695.1 | ||||
UCP2 | ENST00000310473.10 | c.*2C>G | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000312029.3 | ||||
UCP2 | ENST00000544615.5 | n.851C>G | non_coding_transcript_exon_variant | Exon 5 of 5 | 2 | |||||
UCP2 | ENST00000536983.5 | c.*73C>G | 3_prime_UTR_variant | Exon 7 of 7 | 5 | ENSP00000441147.1 |
Frequencies
GnomAD3 genomes AF: 0.00124 AC: 169AN: 136008Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
169
AN:
136008
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000218 AC: 53AN: 243456 AF XY: 0.000212 show subpopulations
GnomAD2 exomes
AF:
AC:
53
AN:
243456
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000107 AC: 155AN: 1442314Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 79AN XY: 717264 show subpopulations
GnomAD4 exome
AF:
AC:
155
AN:
1442314
Hom.:
Cov.:
31
AF XY:
AC XY:
79
AN XY:
717264
show subpopulations
African (AFR)
AF:
AC:
134
AN:
33030
American (AMR)
AF:
AC:
9
AN:
43688
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25522
East Asian (EAS)
AF:
AC:
0
AN:
38624
South Asian (SAS)
AF:
AC:
1
AN:
85654
European-Finnish (FIN)
AF:
AC:
0
AN:
51602
Middle Eastern (MID)
AF:
AC:
0
AN:
5658
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1099450
Other (OTH)
AF:
AC:
10
AN:
59086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00125 AC: 170AN: 136130Hom.: 1 Cov.: 31 AF XY: 0.00116 AC XY: 77AN XY: 66492 show subpopulations
GnomAD4 genome
AF:
AC:
170
AN:
136130
Hom.:
Cov.:
31
AF XY:
AC XY:
77
AN XY:
66492
show subpopulations
African (AFR)
AF:
AC:
163
AN:
38018
American (AMR)
AF:
AC:
7
AN:
12780
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3204
East Asian (EAS)
AF:
AC:
0
AN:
4802
South Asian (SAS)
AF:
AC:
0
AN:
4434
European-Finnish (FIN)
AF:
AC:
0
AN:
9030
Middle Eastern (MID)
AF:
AC:
0
AN:
244
European-Non Finnish (NFE)
AF:
AC:
0
AN:
60958
Other (OTH)
AF:
AC:
0
AN:
1838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Jun 01, 2020
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.